TNF-Alpha Inhibitors - 8 Angebote vergleichen
| Preise | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Schnitt | € 161,91 | € 146,88 | € 115,19 | € 128,39 | € 87,17 |
| Nachfrage |
1
TNF-alpha Inhibitors
DE NW EBISBN: 9783764372484 bzw. 3764372486, in Deutsch, Birkhuser Basel, neu, E-Book.
Lieferung aus: Vereinigte Staaten von Amerika, E-Book zum download.
Medicine, Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. Elucidation of the complex web of cytokine network and the roles of these cytokines in the pat- genesis of inflammatory disorders provided one of the key catalysts for the advancement of targeted biologic therapy in autoimmune and inflammatory diseases. TNF-? is known to play a crucial role in the pathogenesis of many chronic inflammatory diseases. Elevated levels of TNF-? have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, sugge- ing a role for TNF-? in their pathogenesis. Although TNF-? plays a critical role in the activation of innate and acquired immune responses, the persistence of the immune response and inappropriate production of TNF-? can produce pathological changes resulting from chronic inflammation and tissue damage. The purpose of this volume is to provide a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-? inhibitors etanercept, infliximab, and adalimumab. The initial three chapters of the volume provide a background on the field on TNF-? and its inhibition. Chapter 1 provides an introduction to TNF and reviews the pathophysiology of this cytokine. Chapter 2 then presents the h- tory of the development of TNF inhibitors. The pharmacology of these agents is reviewed in Chapter 3. eBook.
Medicine, Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. Elucidation of the complex web of cytokine network and the roles of these cytokines in the pat- genesis of inflammatory disorders provided one of the key catalysts for the advancement of targeted biologic therapy in autoimmune and inflammatory diseases. TNF-? is known to play a crucial role in the pathogenesis of many chronic inflammatory diseases. Elevated levels of TNF-? have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, sugge- ing a role for TNF-? in their pathogenesis. Although TNF-? plays a critical role in the activation of innate and acquired immune responses, the persistence of the immune response and inappropriate production of TNF-? can produce pathological changes resulting from chronic inflammation and tissue damage. The purpose of this volume is to provide a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-? inhibitors etanercept, infliximab, and adalimumab. The initial three chapters of the volume provide a background on the field on TNF-? and its inhibition. Chapter 1 provides an introduction to TNF and reviews the pathophysiology of this cytokine. Chapter 2 then presents the h- tory of the development of TNF inhibitors. The pharmacology of these agents is reviewed in Chapter 3. eBook.
2
TNF-Alpha Inhibitors
DE NWISBN: 9783764372484 bzw. 3764372486, in Deutsch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, neu.
Lieferung aus: Deutschland, 2-3 Werktage.
This volume provides a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-alpha inhibitors. It is the first volume that summarizes this material for all available TNF-alpha inhibitors. Elevated levels of TNF-alpha have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, suggesting a role for TNF-alpha in their pathogenesis. The most recent preclinical and clinical data is presented in this book. von Weinberg, Jeffrey M. und Buchholz, Robi, Neu.
This volume provides a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-alpha inhibitors. It is the first volume that summarizes this material for all available TNF-alpha inhibitors. Elevated levels of TNF-alpha have been demonstrated in Crohn's disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, suggesting a role for TNF-alpha in their pathogenesis. The most recent preclinical and clinical data is presented in this book. von Weinberg, Jeffrey M. und Buchholz, Robi, Neu.
3
TNF-Alpha Inhibitors
DEISBN: 9783764372484 bzw. 3764372486, in Deutsch, Birkhauser.
Lieferung aus: Vereinigte Staaten von Amerika, Lagernd, zzgl. Versandkosten.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
TNF-Alpha Inhibitors (2006)
~EN HC NWISBN: 9783764372484 bzw. 3764372486, vermutlich in Englisch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, gebundenes Buch, neu.
Lieferung aus: Deutschland, Next Day, zzgl. Versandkosten.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
6
TNF-Alpha Inhibitors (2006)
~EN NWISBN: 3764372486 bzw. 9783764372484, vermutlich in Englisch, Springer Basel AG, neu.
Von Händler/Antiquariat, MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
7
TNF-alpha Inhibitors
~EN HC NWISBN: 9783764372484 bzw. 3764372486, vermutlich in Englisch, Birkenhäuser Verlag, Basel/Boston/Stuttgart, Schweiz, gebundenes Buch, neu.
Lieferung aus: Deutschland, 1-2 Werktage.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
8
TNF-Alpha Inhibitors (2006)
DE NWISBN: 3764372486 bzw. 9783764372484, in Deutsch, Springer Basel AG; Springer Basel, neu.
Von Händler/Antiquariat, MARZIES.de Buch- und Medienhandel, 14621 Sch.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…